Stay up to date with market trends for plasmid DNA (pDNA) as both a reagent for advanced therapies and as a primary therapeutic. Our Market Insight report provides essential market intelligence from innovators, CDMO owners, PhDs and researchers across advanced therapeutics to fully understand plasmids’ role in advanced therapeutics.
Measure your business against your peers using our robust analysis of the pDNA contract development and manufacturing market. Our pricing matrix comprises material cost, infrastructure and development process data from across the industry so you can make informed decisions to best position your business.
